← brief for 2026-08-29 · Slowing decline

Prevention and Management of Carboplatin Nephrotoxicity

Key takeaways

A review of how to prevent and handle kidney damage caused by carboplatin, a common chemotherapy drug. It gathers current practice on dosing, fluids, and monitoring to protect the kidneys during cancer treatment. It is a summary of what is already known and reports no new study results.

Who did this work

Renato A. Caires (Instituto do Câncer do Estado de São Paulo) · Elerson C. Costalonga (Renal Association) · Verônica Torres Costa e Silva (Universidade de São Paulo)

Source

Paper · OpenAlex, CKD works · 2026-08-28
https://doi.org/10.3390/cancers18172801